Spectrum and Prevalence of CALM1 -, CALM2 -, and CALM3 -Encoded Calmodulin Variants in Long QT Syndrome and Functional Characterization of a Novel Long QT Syndrome–Associated Calmodulin Missense Variant, E141G
Author(s) -
Nicole J. Boczek,
Nieves GómezHurtado,
Dan Ye,
Melissa L. Calvert,
David J. Tester,
Dmytro O. Kryshtal,
Hyun Seok Hwang,
Christopher N. Johnson,
Walter Chazin,
Christina G. Loporcaro,
Maully J. Shah,
Andrew L. Papez,
Yung R. Lau,
Ronald J. Kanter,
Björn C. Knollmann,
Michael J. Ackerman
Publication year - 2016
Publication title -
circulation cardiovascular genetics
Language(s) - English
Resource type - Journals
eISSN - 1942-325X
pISSN - 1942-3268
DOI - 10.1161/circgenetics.115.001323
Subject(s) - exome sequencing , nonsynonymous substitution , ryanodine receptor 2 , calmodulin , cohort , exome , genetics , medicine , long qt syndrome , biology , ryanodine receptor , endocrinology , qt interval , phenotype , calcium , gene , genome
Calmodulin (CaM) is encoded by 3 genes, CALM1, CALM2, and CALM3, all of which harbor pathogenic variants linked to long QT syndrome (LQTS) with early and severe expressivity. These LQTS-causative variants reduce CaM affinity to Ca(2+) and alter the properties of the cardiac L-type calcium channel (CaV1.2). CaM also modulates NaV1.5 and the ryanodine receptor, RyR2. All these interactions may play a role in disease pathogenesis. Here, we determine the spectrum and prevalence of pathogenic CaM variants in a cohort of genetically elusive LQTS, and functionally characterize the novel variants.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom